148 related articles for article (PubMed ID: 37126418)
1. Interfering with Interferons: A Critical Mechanism for Critical COVID-19 Pneumonia.
Su HC; Jing H; Zhang Y; Casanova JL
Annu Rev Immunol; 2023 Apr; 41():561-585. PubMed ID: 37126418
[TBL] [Abstract][Full Text] [Related]
2. Human genetics of SARS-CoV-2 infection and critical COVID-19.
Mogensen TH
Clin Microbiol Infect; 2022 Nov; 28(11):1417-1421. PubMed ID: 35218979
[TBL] [Abstract][Full Text] [Related]
3. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
4. Insufficient type I IFN immunity underlies life-threatening COVID-19 pneumonia.
Bastard P; Zhang Q; Cobat A; Jouanguy E; Zhang SY; Abel L; Casanova JL
C R Biol; 2021 Jun; 344(1):19-25. PubMed ID: 34213846
[TBL] [Abstract][Full Text] [Related]
5. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies Neutralizing Type III Interferons Are Uncommon in Patients with Severe Coronavirus Disease 2019 Pneumonia.
Vanker M; Särekannu K; Fekkar A; Jørgensen SE; Haljasmägi L; Kallaste A; Kisand K; Lember M; Peterson P; Menon M; Hussell T; Knight S; Moore-Stanley J; Bastard P; Zhang SY; Mogensen TH; Philippot Q; Zhang Q; Puel A; Casanova JL; Kisand K
J Interferon Cytokine Res; 2023 Sep; 43(9):379-393. PubMed ID: 37253131
[TBL] [Abstract][Full Text] [Related]
7. Human genetic and immunological determinants of critical COVID-19 pneumonia.
Zhang Q; Bastard P; ; Cobat A; Casanova JL
Nature; 2022 Mar; 603(7902):587-598. PubMed ID: 35090163
[TBL] [Abstract][Full Text] [Related]
8. Human Genomics of COVID-19 Pneumonia: Contributions of Rare and Common Variants.
Cobat A; Zhang Q; ; Abel L; Casanova JL; Fellay J
Annu Rev Biomed Data Sci; 2023 Aug; 6():465-486. PubMed ID: 37196358
[TBL] [Abstract][Full Text] [Related]
9. Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia.
de Prost N; Bastard P; Arrestier R; Fourati S; Mahévas M; Burrel S; Dorgham K; Gorochov G; Tandjaoui-Lambiotte Y; Azzaoui I; Fernandes I; Combes A; Casanova JL; Mekontso-Dessap A; Luyt CE
J Clin Immunol; 2021 Apr; 41(3):536-544. PubMed ID: 33616813
[TBL] [Abstract][Full Text] [Related]
10. Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain.
Troya J; Bastard P; Planas-Serra L; Ryan P; Ruiz M; de Carranza M; Torres J; Martínez A; Abel L; Casanova JL; Pujol A
J Clin Immunol; 2021 Jul; 41(5):914-922. PubMed ID: 33851338
[TBL] [Abstract][Full Text] [Related]
11. Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs.
Casanova JL; Anderson MS
J Clin Invest; 2023 Feb; 133(3):. PubMed ID: 36719370
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies Neutralizing Type I Interferons in 20% of COVID-19 Deaths in a French Hospital.
Chauvineau-Grenier A; Bastard P; Servajean A; Gervais A; Rosain J; Jouanguy E; Cobat A; Casanova JL; Rossi B
J Clin Immunol; 2022 Apr; 42(3):459-470. PubMed ID: 35083626
[TBL] [Abstract][Full Text] [Related]
13. Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity.
Smith N; Possémé C; Bondet V; Sugrue J; Townsend L; Charbit B; Rouilly V; Saint-André V; Dott T; Pozo AR; Yatim N; Schwartz O; Cervantes-Gonzalez M; Ghosn J; Bastard P; Casanova JL; Szwebel TA; Terrier B; Conlon N; O'Farrelly C; Cheallaigh CN; Bourke NM; Duffy D
Nat Commun; 2022 Nov; 13(1):7254. PubMed ID: 36434007
[TBL] [Abstract][Full Text] [Related]
14. Infection-induced inflammation from specific inborn errors of immunity to COVID-19.
Ku CL; Chen IT; Lai MZ
FEBS J; 2021 Sep; 288(17):5021-5041. PubMed ID: 33971084
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Neutralizing Autoantibodies Against Type I Interferon in a Multicenter Cohort of Severe or Critical COVID-19 Cases in Shanghai.
Shi D; Chen J; Zhao M; Tang Y; Zhao C; Jin Y; Tian D; Liao Y; Wang X; Wang W; Fan X; Yi Z; Chen X; Ling Y
J Clin Immunol; 2024 Mar; 44(3):80. PubMed ID: 38462559
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against type I interferons in COVID-19 infection: A systematic review and meta-analysis.
Wang X; Tang Q; Li H; Jiang H; Xu J; Bergquist R; Qin Z
Int J Infect Dis; 2023 May; 130():147-152. PubMed ID: 36907547
[TBL] [Abstract][Full Text] [Related]
17. Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona.
Solanich X; Rigo-Bonnin R; Gumucio VD; Bastard P; Rosain J; Philippot Q; Perez-Fernandez XL; Fuset-Cabanes MP; Gordillo-Benitez MÁ; Suarez-Cuartin G; Boza-Hernandez E; Riera-Mestre A; Parra-Martínez A; Colobran R; Antolí A; Navarro S; Rocamora-Blanch G; Framil M; Calatayud L; Corbella X; Casanova JL; Morandeira F; Sabater-Riera J
J Clin Immunol; 2021 Nov; 41(8):1733-1744. PubMed ID: 34570326
[TBL] [Abstract][Full Text] [Related]
18. Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia.
Zhang Q; Matuozzo D; Le Pen J; Lee D; Moens L; Asano T; Bohlen J; Liu Z; Moncada-Velez M; Kendir-Demirkol Y; Jing H; Bizien L; Marchal A; Abolhassani H; Delafontaine S; Bucciol G; ; Bayhan GI; Keles S; Kiykim A; Hancerli S; Haerynck F; Florkin B; Hatipoglu N; Ozcelik T; Morelle G; Zatz M; Ng LFP; Lye DC; Young BE; Leo YS; Dalgard CL; Lifton RP; Renia L; Meyts I; Jouanguy E; Hammarström L; Pan-Hammarström Q; Boisson B; Bastard P; Su HC; Boisson-Dupuis S; Abel L; Rice CM; Zhang SY; Cobat A; Casanova JL
J Exp Med; 2022 Aug; 219(8):. PubMed ID: 35708626
[TBL] [Abstract][Full Text] [Related]
19. Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome.
Abolhassani H; Landegren N; Bastard P; Materna M; Modaresi M; Du L; Aranda-Guillén M; Sardh F; Zuo F; Zhang P; Marcotte H; Marr N; Khan T; Ata M; Al-Ali F; Pescarmona R; Belot A; Béziat V; Zhang Q; Casanova JL; Kämpe O; Zhang SY; Hammarström L; Pan-Hammarström Q
J Clin Immunol; 2022 Apr; 42(3):471-483. PubMed ID: 35091979
[TBL] [Abstract][Full Text] [Related]
20. Type I and type III interferons: From basic biology and genetics to clinical development for COVID-19 and beyond.
Andreakos E;
Semin Immunol; 2024 Mar; 72():101863. PubMed ID: 38271892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
